Category: Headlines

Verona Pharma (NASDAQ: VRNA) shareholders have approved the company’s proposed $10 billion acquisition by Merck (NYSE: MRK). The transaction, announced on July 8, 2025, values Verona at $107 per American Depositary Share (ADS), with each ADS representing eight ordinary shares. The acquisition, structured as a scheme of arrangement under English law, received overwhelming shareholder support with 99.49% approval at the Court Meeting and 99.51% approval at the General Meeting. The transaction is expected to close on October 7, 2025, subject to final Court sanction at a hearing scheduled for October 6, 2025. Verona shareholders approved Merck’s $10B acquisition at $107/ADS, expected to close October 7 following court approval. The overwhelming shareholder approval of Merck’s acquisition of Verona Pharma marks a critical milestone for this substantial transaction. With 99.49% of voting shares supporting the scheme and 99.51% approving the necessary administrative changes, shareholders have delivered a resounding endorsement of the $10 billion deal valued at $107 per ADS. This acquisition represents significant value for Verona shareholders. Each ADS represents eight ordinary Verona shares, and the transaction has now cleared a major hurdle in the UK’s two-step acquisition process. The remaining step is purely procedural – the High Court of Justice of England and Wales must sanction the scheme on October 6, with the transaction expected to close the following day. The transaction’s structure as a scheme of arrangement under English law provides tax and timing efficiencies compared to traditional tender offers. The executive compensation package also received strong support with 81.19% approval, indicating shareholder satisfaction with management’s handling of the transaction. For Merck, this acquisition aligns with their strategy to expand their respiratory disease portfolio, an area where Verona has established specialized expertise. Once completed on the expected date of October 7, Verona shareholders will receive their consideration promptly, with payments occurring between October 8-14. Source: https://www.stocktitan.net/news/VRNA/shareholders-of-verona-pharma-approve-proposed-acquisition-by-088bpcz5xng2.html

Great Southern Bank and P&N Group have signed a memorandum of understanding (MoU) to explore a merger which would create one of the largest customer-owned banking entities in the country. The merger would bring together Great Southern Bank’s footprint across Queensland, New South Wales and Victoria with P&N Bank’s footprint in Western Australia. P&N Bank also owns BCU Bank in Northern NSW and southeast Queensland, which would also be incorporated into the merged entity. The merged entity would become one of Australia’s largest customer-owned banks, with total assets of around $30 billion. It would operate out of dual head offices in Perth and Brisbane, alongside regional offices in Coffs Harbour, Sydney, and Melbourne. P&N Group chair Gary Humphreys believes the merger would deliver benefits for customers, employees, and communities. He said: “We have been deliberate in our choice of partnering with Great Southern Bank for this potential merger opportunity. We believe that our customers will benefit from being a part of one of Australia’s leading customer and community-focused banks. “Great Southern Bank is a financially strong Australian customer-owned bank with a solid reputation and shared values. The prospect of enhancing our shared commitment to face to face customer service and the personal touch our customers love, is an exciting one for our employees and our customers.” Great Southern Bank chief executive Paul Lewis (pictured, left, alongside P&N Bank chief executive Andrew Hadley) added: “A merger with P&N Group gives us the scale to continue investing in our people and communities, ensuring a relevant, resilient, and sustainable bank that meets the needs of current and future generations of Australians.” Source: https://www.mpamag.com/au/news/general/great-southern-bank-pn-group-announce-merger-talks/550388

TUALATIN, Ore., Sept. 17, 2025 /PRNewswire/ — SAM Medical, a leading provider of pre-hospital emergency medical products, is pleased to announce the acquisition of TyTek Medical, part of the TyTek Group. TyTek Medical is a globally known, leading provider of chest decompression needles. The acquisition of TyTek Medical marks a significant expansion of SAM Medical’s proprietary offering of emergency medical products, further solidifying its leadership position in the emergency medical market. “I am confident the acquisition by SAM Medical will provide our customers and suppliers continued success with the same confidence in quality and customer service they’ve come to trust,” said Chris Tyler, President and CEO of TyTek Group. “The acquisition of TyTek Medical strengthens our ability to deliver a comprehensive range of solutions for emergency medical professionals,” said Jim Seidel, CEO of SAM Medical. “TyTek’s strong reputation for high-quality, life-saving products aligns perfectly with our commitment to support first responders in their most critical moments. This acquisition better positions us to set the standard in the markets we serve.” The TyTek Medical operations will be moved to Tualatin and leverage the first-class team assembled there. The global reach of SAM Medical will broaden customer support for this best-in-class line of chest decompression needles. About TyTek Medical TyTek Medical designs and manufactures compact pre-hospital emergency medical supplies for trauma care. Their proven line of emergency medical products allows first responders to administer life-saving trauma care, stabilizing patients until they can be transported. About SAM Medical Founded by Dr. Sam and Cherrie Scheinberg, SAM Medical has a distinguished history of revolutionizing emergency medical care products for the trauma management field. As a Board-Certified Orthopedic Surgeon and Vietnam War-tested trauma surgeon, Dr. Scheinberg pioneered many cutting-edge and life-saving products over the years, including the widely known SAM® Splint. The company also is well known for its SAM® XT Extremity Tourniquet and SAM® IO Intraosseous Access System, among other innovative products. Based near Portland, Oregon, SAM® Medical is at the forefront of developing proprietary medical products that are vital for saving lives. SAM® products have been trusted globally for more than 40 years by a wide array of caregivers supporting emergency medical professionals, wilderness explorers, sports medicine specialists, security forces and pre-hospital emergency providers. The company’s innovative approach to medical device engineering has made them a key player in the emergency medical industry. Innovations include the SAM® Splint, SAM® XT Extremity Tourniquet, SAM® IO Intraosseous Access System, SAM® Chest Seal, SAM® Junctional Tourniquet (SJT), SAM® Pelvic Sling and ChitoSAM™. SAM Medical is a wholly owned subsidiary of Tri-Tech Forensics, Inc. SOURCE SAM Medical Source: https://www.prnewswire.com/news-releases/sam-medical-expands-emergency-medical-offering-with-strategic-acquisition-of-tytek-medical-302559671.html

Peak Rare Earths, a company based in Australia, said it had approved the takeover of Shenghe Resources by a Chinese rare earths producer. The decision was made to choose certainty over a more lucrative but conditional U.S. bid. Shenghe Singapore will purchase all shares of Peak that it does not own at A$0.443 per share. This value is A$195 ($129.9 millions) for the miner. The Chinese company holds a stake of about 19.7% in the Australian miner. The approval came after General Innovation Capital Partners, a U.S.-based company, made a non-binding bid of A$240m. rejected The bid was rejected earlier on Tuesday due to a lack of clarity regarding due diligence and execution. Shenghe has said that it will not support the proposal of GICP. Shenghe is a partly state-owned company raised Its offer, which was made earlier in the month, increased by over 23% mid-May . This would allow it to control Peak’s Ngualla Project in Tanzania, which is one of the largest deposits of neodymium & praseodymium(NdPr), crucial for electric vehicles. Shenghe is expanding its presence in Australia’s rare-earths sector. In 2022, Shenghe purchased nearly 20% of Peak and signed a contract to buy Ngualla products that same year. Canberra is examining the possibility of a deal. Price floor Support critical mineral projects and position yourself as an alternative supplier to China. The peak share price rose by 3.6%, to A$0.435 at 0313 GMT. This is the highest it has been in over two years. (source: Reuters) Source: https://energynews.oedigital.com/mining/2025/09/16/peak-rare-earths-australias-rare-earths-company-accepts-a-130-million-shenghe-bid-rejects-a-higher-us-offer

A Singapore-based holding company is taking over Indonesian retail giant PT Mitra Adiperkasa Tbk, which runs hundreds of stores in the Philippines including Planet Sports and Foot Locker outlets.The Philippine Competition Commission (PCC), which reviews mergers and acquisitions, cleared the deal after finding no risk of reduced competition. The buyer, Pacific Universal Investments Pte. Ltd., is acquiring shares in Jakarta-based PT Mitra from PT Satya Mulia Gema Gemilang, which holds a 51 percent controlling stake, the company’s regulatory filings in Indonesia showed. PT Mitra has a regional footprint of 3,832 stores across seven ASEAN countries, with 247 outlets and 21 exclusive brands in the Philippines alone. Its subsidiaries include MAP Active Philippines (Foot Locker, Planet Sports, New Balance, Converse, Sketchers) and Mapple Philippines Inc., which sells Apple products. In a decision dated Aug. 12, 2025, regulators said the firms are not direct rivals and that other established retailers provide enough competition. The approval was issued under the Philippine Competition Act, which requires PCC to vet major deals that could affect consumers. Source: https://insiderph.com/singapore-firm-buys-indonesian-retailer-that-owns-foot-locker-planet-sports-outlets-in-the-philippines

The purchase of AACG’s three facilities – a combined 379 beds – brings Opal HealthCare’s portfolio to 142 care communities nationwide, including 56 in Victoria. The three homes are: Phillip Island Grove Care Community in Cowes, 150km south of Melbourne, with RADs up to $575,000Mount Eliza Botanica Care Community on the Mornington Peninsula, with RADs up to $1.9 millionKew Botanica Care Community, 5km east of the Melbourne CBD, with RADs up to $2 million Founded in the 1960s by Keith and Betty Matthies, AACG was among the pioneers of purpose-built aged care in Melbourne. Their son, John Matthies, later became Managing Director and continued to expand the family legacy. Opal HealthCare CEO Rachel Argaman OAM welcomed AACG residents, families and staff into the fold. “We’re privileged to be entrusted with the extraordinary legacy of Australian Aged Care Group,” she said. “We’ll bring the best of our two organisations together to meet the needs of ageing Australians and provide the care, services and lifestyle options they not only expect, but want to enjoy through all the stages of ageing.” Expansion in overdriveOpal HealthCare is 50% owned by private equity firm Pacific Equity Partners and Singaporean investment group G. K. Goh Holdings. With their backing, the operator has adopted one of the most aggressive growth strategies in the sector. March 2024: Acquired BlueCross’ 31 homes in Victoria, also marking its entry into home care.May 2025: Purchased the five luxury homes of Cranbrook Care.Current pipeline: Multiple new builds underway in Sydney (Narwee, St Clair, St Ives) and Melbourne (Brighton, Caulfield).The retirement living connectionOpal is also investing in integrated precincts that combine aged care with retirement living. Croydon Grove Care Community in Melbourne (121 beds) co-located with Aveo’s Mingarra Retirement Living community.Epping Grand Care Community in Sydney (132 beds) due to open November 2025 across six floors of Levande’s 28-storey vertical village, The Cambridge.With the AACG deal complete, Opal has cemented its position as the country’s biggest aged care provider – and shows no sign of slowing its acquisition drive. Source: https://www.theweeklysource.com.au/acquisitions/opal-healthcare-powers-ahead-with-triple-victorian-acquisition

Japanese retail giant Seven & i Holdings has confirmed the completion of its subsidiary sale, York Holdings, to US-based private equity firm Bain Capital. Seven & i stated that procedures for the “absorption-type split” were completed on 1 September 2025. York Holdings was established in October 2024 as a fully owned entity under Seven & i Holdings, and manages 29 subsidiaries and affiliates. The portfolio includes supermarket chains such as Ito-Yokado and York-Benimaru, along with retailers such as Loft, Akachan Honpo and Seven & i Food Systems, which operates the Denny’s family restaurant chain. In March 2025, Bain Capital disclosed that it had entered into a definitive agreement to purchase the headquarters of York Holdings and its subsidiary management functions. This acquisition, valued at Y814.7bn ($5.5bn), encompasses York Holdings’ supermarket and speciality store divisions. Bain Capital reached an agreement with Seven & i on a company split in which the latter will partially reinvest in the business post-transaction. Seven & i has also announced that the “reinvestment has been completed”. The company “remains fully committed to pursuing all avenues to unlock value for shareholders”. The development follows Canadian retailer Alimentation Couche-Tard withdrawing from its $47bn buyout proposal to buy Seven & i in July 2025. In August, the Japanese retailer unveiled plans to launch 1,300 new stores in North America by the fiscal year 2030. It also plans to establish 1,000 additional outlets in Japan, as part of its revised midterm strategy. In March 2025, Seven & i named Stephen Hayes Dacus as its new CEO to accelerate the implementation of strategic priorities.   Source: https://www.retail-insight-network.com/news/seven-i-absorption-type-split-york-holdings/?cf-view

Japanese insurer Sompo Holdings – advised by Skadden, Arps, Slate, Meagher & Flom – has entered into a definitive merger agreement to acquire 100% of the issued class A ordinary shares of American peer Aspen Insurance Holdings, which was advised by Sidley Austin, at around USD3.5 billion. Partners Sean Carney and Jonathan Blackburn led the Sidley team, while the Skadden team was headed by partners Todd Freed and Patrick Lewis. “We advised Aspen in connection with identifying insurance regulatory approvals worldwide that would be required in connection with the buyer’s acquisition of control of Aspen and its subsidiaries, including in the United States and United Kingdom,” Carney told Asia Business Law Journal. He also said the firm worked with Bermuda and local counsel where necessary in other jurisdictions. Filings would be made between now and closing where required, added Carney. The transaction is subject to customary regulatory approvals and is expected to close in the first half of 2026. On completion, all series of Aspen’s preference shares will remain outstanding with no changes to their relative rights, terms or conditions. However, Sompo and Aspen may periodically explore options to redeem, repurchase or delist the preferred shares or associated depositary shares. Source: https://law.asia/sidley-skadden-advise-sompo-aspen-3-5bn-insurance-merger/

(RTTNews) – CoStar Group, Inc. (CSGP) has completed its acquisition of Domain Holdings Australia Limited, one of Australia’s top property marketplaces. The deal combines CoStar’s global scale, technology leadership, and pro-agent approach with Domain’s strong local brand and deep market expertise. CEO Andy Florance said the merger aims to create a more balanced marketplace for agents, vendors, and buyers, challenging legacy models that prioritize extracting value over delivering it. He emphasized that CoStar will invest in better tools, content, and user experiences while reducing costs, replicating its success transforming Homes.com in the U.S. Domain President Jason Pellegrino noted that the partnership will accelerate innovation and expand opportunities for customers while reinforcing Domain’s trusted position in the market. Both companies plan to enhance digital tools, customer solutions, and technology integration to set new standards of fairness, competition, and value in Australia’s real estate industry. CSGP currently trades at $88.57 or 0.89% lower on the NasdaqGS. Source: https://www.nasdaq.com/articles/costar-group-completes-acquisition-domain-reshape-australias-property-market

Aspen Insurance (NYSE:AHL) stock was surging after Japan-based Sompo Holdings (OTCPK:NHOLF) (OTCPK:SMPNY) announced an ~$3.5B acquisition of the specialty insurer. AHL shares were +11.74% Wednesday pre-market to $35.99. The unit Sompo International Holdings has entered into a definitive agreement to purchase 100% of the issued class A shares of Aspen for $37.50 per share in cash. Media reports about Sompo Holdings being in talks to acquire the insurer had surfaced on August 20. The consideration represents a 35.6% premium to the August 19 unaffected share price of $27.66, and 24.6% to the unaffected 30-day volume-weighted average price as of August 19. The deal is expected to be immediately accretive to Sompo’s return on equity. The transaction, unanimously approved by boards of both companies, is expected to close in the first half of 2026. Source: https://seekingalpha.com/news/4489562-aspen-stock-jumps-on-35b-acquisition-by-japan-based-sompo